as 11-20-2024 4:00pm EST
Staar Surgical Co is a manufacturer of lenses. It designs, develops, manufactures, and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The company also makes lenses that are used in surgery to treat cataracts. The company offers two types of products: Implantable Collamer lenses (ICL) and intraocular lens (IOL). The ICLs are used in refractive surgery and IOLs are used in cataract surgery. The majority of sales are generated from the ophthalmic surgical product segment.
Founded: | 1982 | Country: | United States |
Employees: | N/A | City: | MONROVIA |
Market Cap: | 1.3B | IPO Year: | N/A |
Target Price: | $43.33 | AVG Volume (30 days): | 641.1K |
Analyst Decision: | Buy | Number of Analysts: | 7 |
Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
EPS: | 0.44 | EPS Growth: | 9.97 |
52 Week Low/High: | $25.89 - $52.68 | Next Earning Date: | 10-30-2024 |
Revenue: | $341,224,000 | Revenue Growth: | 10.01% |
Revenue Growth (this year): | 8.45% | Revenue Growth (next year): | 12.35% |
STAA Breaking Stock News: Dive into STAA Ticker-Specific Updates for Smart Investing
Zacks
8 days ago
Business Wire
8 days ago
Argus Research
8 days ago
Argus Research
15 days ago
Zacks
17 days ago
GuruFocus.com
19 days ago
Simply Wall St.
19 days ago
Simply Wall St.
20 days ago
The information presented on this page, "STAA STAAR Surgical Company - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.